Pharmacist-Led Adherence Strategies for Patients Living With TD
Panelists discuss how pharmacists enhance treatment adherence in older adults with tardive dyskinesia by assessing cognitive function, involving caregivers, linking…
1049: If you can get your lab to do with this urine cultures you’ll use fewer antibiotics
Show notes at pharmacyjoe.com/episode1049. In this episode, I’ll discuss conditional reflex urine culturing for antibiotic stewardship. The post 1049: If…
IVIG Therapy: Mechanisms, Formulations, and Key Considerations for Safe and Effective Use
Intravenous immunoglobulin (IVIG) is a vital treatment for immunodeficiency and autoimmune disorders, with diverse mechanisms, brand-specific differences, and patient-centered considerations…
Video: Pharmacists Take Center Stage in Delivering Linvoseltamab, Advancing Myeloma Care
Sundar Jagannath, MBBS, highlights pharmacists’ expanding role in managing linvoseltamab’s immunologic profile, supporting adverse event response, and advancing multiple myeloma…
From Clinic to Hospital: Oncology Pharmacists Driving Seamless Site-of-Care Transitions
Eileen Peng, PharmD, discusses how her team has restructured pharmacy services to support outpatient administration of CAR T-cell and bispecific…
Shaping the Future of Pharmacy Leadership Through Complementary Perspectives at UNC Health
Two pharmacy leaders at UNC Health share how their distinct yet complementary leadership journeys and skill sets are driving innovation…
Championing the Role of Oncology Pharmacists in Patient-Centered Cancer Care
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA, FASTCT, discusses the collaborative culture, research opportunities, and leadership pathways that define oncology pharmacy…
Unlocking the Full Potential of Pharmacists in Medication Safety
Maximizing pharmacists’ impact on medication safety requires removing barriers to intervention and empowering proactive clinical roles.
Vizz Becomes First, Only FDA-Approved Aceclidine-Based Eye Drop for Presbyopia
The FDA approves aceclidine ophthalmic solution 1.44%, the first aceclidine eye drop for presbyopia, offering a new solution for millions…
Inclisiran Receives FDA Approval for New Indication to Treat Hypercholesterolemia
FDA approves inclisiran as a monotherapy to effectively lower low-density lipoprotein cholesterol in adults with hypercholesterolemia, enhancing heart disease prevention…